BioCryst Pharmaceuticals, Inc. (BCRX) vs Inspire Medical Systems, Inc. (INSP)

A side-by-side comparison of BioCryst Pharmaceuticals, Inc. and Inspire Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BCRX vs INSP

growth of $100 · dividends reinvested · last 8y
BCRX +60.4% (+6.1%/yr)INSP +183.2% (+13.9%/yr)INSP compounded faster over this window
05001kStart $1002020202220242026$160$283
BCRX INSP

BCRX vs INSP: by the numbers

  • •BCRX is the larger company ($2.06B vs $2.05B market cap).
  • •INSP is profitable (15.03% net margin) while BCRX runs a net loss (-40.90%).
  • •BCRX grew revenue faster over the past five years (64.07% vs 38.69% CAGR).

Metrics side by side

Valuation

MetricBCRXINSP
P/E ratioN/A15.31
Forward P/EN/A59.24
P/S ratio2.192.28
P/B ratioN/A2.48
EV / EBITDAN/A27.29
FCF yield17.35%5.72%

Profitability

MetricBCRXINSP
Gross margin97.82%86.13%
Operating margin38.98%6.02%
Net margin-40.90%15.03%
ROEN/A16.36%
ROIC-89.73%6.33%

Growth (annualized)

MetricBCRXINSP
Revenue CAGR (5Y)64.07%38.69%
Total return CAGR (5Y)-10.02%-21.38%

Frequently asked

Which has grown faster, BCRX or INSP?
Over the past five years, BCRX grew revenue faster — BCRX at a 64.07% CAGR versus INSP at 38.69%.
Is BCRX or INSP more profitable?
INSP runs the higher net margin — BCRX at -40.90% versus INSP at 15.03%.
How have BCRX and INSP total returns compared?
Over the past 5 years, BCRX delivered -10.02% and INSP delivered -21.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.